Optimi Health Corp. Common Shares (OPTH) Stock Price

OPTHStock

$3.38+1115.38%52W

Market Cap$19.35M

P/E—

PEG Ratio—

Div yield—

Beta0.55

OPTH Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)1444.19%

Price vs S&P 500 (4W)-30.38%

VGM Score37.83

Book Value / Share (Quarterly)$65.39

P/TBV (Annual)0.90x

Cash Flow / Share (Quarterly)$-19.69

Price vs S&P 500 (YTD)1392.84%

Gross Margin (TTM)65.11%

Net Profit Margin (TTM)-1667.21%

EPS (TTM)$-22.71

10-Day Avg Trading Volume0.00M

EPS Excl Extra (TTM)$-22.71

EPS (Annual)$-0.82

ROI (Annual)-28.36%

Gross Margin (Annual)3.65%

Cash / Share (Quarterly)$48.47

Revenue Growth QoQ (YoY)-28.61%

ROA (Last FY)-24.40%

Revenue Growth TTM (YoY)-57.81%

EBITD / Share (TTM)$-2.96

ROE (5Y Avg)-46.66%

Operating Margin (TTM)-1668.78%

Cash Flow / Share (Annual)$-0.60

P/B Ratio1.48x

P/B Ratio (Quarterly)2.36x

Net Income / Employee (Annual)$-291,826

EV / Revenue (TTM)75.61x

Net Interest Coverage (TTM)-63.10x

ROA (TTM)-31.06%

EPS Incl Extra (Annual)$-0.82

Current Ratio (Annual)0.22x

Quick Ratio (Quarterly)1.62x

3-Month Avg Trading Volume0.01M

52-Week Price Return1115.38%

Revenue / Employee (TTM)$18,823

Tangible BV / Share (Quarterly)$0.11

P/S Ratio (Annual)61.11x

Asset Turnover (Annual)0.03x

52-Week High$8.07

EPS Excl Extra (Annual)$-0.82

CapEx CAGR (5Y)-34.88%

26-Week Price Return1454.10%

Quick Ratio (Annual)0.15x

13-Week Price Return-26.85%

Total Debt / Equity (Annual)0.99x

Current Ratio (Quarterly)1.73x

Enterprise Value$12.82M

Asset Turnover (TTM)0.01x

Revenue / Employee (Annual)$33,542

Inventory Turnover (Annual)0.68x

Pretax Margin (Annual)-870.76%

Cash / Share (Annual)$0.25

3-Month Return Std Dev62.98%

Net Income / Employee (TTM)$-436,395

ROE (Last FY)-56.49%

Net Interest Coverage (Annual)-12.73x

EPS Basic Excl Extra (Annual)$-0.82

Receivables Turnover (TTM)1.58x

Total Debt / Equity (Quarterly)0.29x

EPS Incl Extra (TTM)$-22.71

Receivables Turnover (Annual)3.89x

ROI (TTM)-37.46%

P/S Ratio (TTM)108.69x

Revenue / Share (Annual)$0.09

Tangible BV / Share (Annual)$0.14

Price vs S&P 500 (52W)1099.85%

Year-to-Date Return1404.76%

5-Day Price Return-16.84%

EPS Normalized (Annual)$-0.82

ROA (5Y Avg)-33.35%

Net Profit Margin (Annual)-870.76%

Month-to-Date Return-29.78%

Cash Flow / Share (TTM)$-0.04

EBITD / Share (Annual)$-0.61

Operating Margin (Annual)-874.11%

LT Debt / Equity (Annual)0.00x

ROI (5Y Avg)-37.16%

LT Debt / Equity (Quarterly)0.00x

EPS Basic Excl Extra (TTM)$-22.71

P/TBV (Quarterly)1.02x

P/B Ratio (Annual)5.67x

Inventory Turnover (TTM)0.18x

Pretax Margin (TTM)-1667.21%

Book Value / Share (Annual)$1.44

Price vs S&P 500 (13W)-29.54%

Beta0.55x

Revenue / Share (TTM)$1.18

ROE (TTM)-63.57%

52-Week Low$0.18

vGradeD

gGradeF

mGradeB

vgmGradeD

Industry Peers — Pharmaceuticals(574)

Symbol	Value Score	Growth Score	Momentum Score	P/S Ratio (TTM)	Revenue Growth TTM (YoY)	Gross Margin (TTM)	EPS Growth (5Y)	Price
OPTHOptimi Health Corp. Common Shares	D	F	B	108.7x	-57.8%	65.1%	—	$3.38
LLYEli Lilly & Co.	D	B	A	14.9x	49.6%	83.4%	27.6%	$1257.03
JNJJohnson & Johnson	D	C	B	6.2x	7.8%	67.7%	14.9%	$255.56
ABBVABBVIE INC.	D	C	A	7.8x	10.4%	72.8%	-2.9%	$285.42
MRKMerck & Co., Inc.	D	C	A	5.4x	4.6%	77.3%	21.2%	$145.95
NVSNovartis AG	C	C	B	4.9x	3.3%	75.0%	15.3%	$150.62
AZNAstraZeneca PLC	C	B	B	4.3x	8.6%	81.3%	21.9%	$165.41
ABTAbbott Laboratories	C	C	B	3.9x	8.1%	56.8%	8.2%	$104.89
NVONovo-Nordisk A/S	B	C	C	3.5x	5.6%	80.7%	20.7%	$38.83
PFEPfizer Inc.	C	D	A	2.6x	-0.2%	74.7%	-3.5%	$29.58
VRTXVertex Pharmaceuticals Inc	D	C	B	10.1x	10.2%	86.0%	8.3%	$499.74
BMYBristol-Myers Squibb Co.	B	B	B	2.5x	3.1%	71.7%	—	$59.75
GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares)	C	C	B	2.3x	5.0%	73.6%	-0.5%	$49.51
SNYSanofi American Depositary Shares (Each representing one-half of one ordinary share)	B	D	B	1.8x	13.4%	72.8%	-8.2%	$40.61
REGNRegeneron Pharmaceuticals Inc	C	C	A	5.2x	9.3%	86.0%	6.3%	$790.74
TAKTakeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)	C	C	A	2.1x	3.1%	65.5%	-12.6%	$19.67
TEVATeva Pharmaceutical Industries Limited	D	C	A	2.8x	4.1%	52.9%	—	$41.50
ONCBeOne Medicines Ltd. American Depositary Shares	D	B	B	6.3x	31.1%	88.5%	—	$369.06
RPRXRoyalty Pharma plc Class A Ordinary Shares	D	D	A	13.8x	10.0%	—	-12.1%	$60.96
ZTSZOETIS INC.	C	C	B	3.5x	1.4%	71.6%	12.0%	$79.38
ALNYAlnylam Pharmaceuticals, Inc.	D	A	C	6.5x	95.1%	79.7%	—	$231.83
ROIVRoivant Sciences Ltd. Common Shares	D	F	B	3215.5x	-67.6%	81.2%	—	$33.53
UTHRUnited Therapeutics Corp	C	C	B	7.2x	2.5%	86.1%	19.3%	$533.12
GMABGenmab A/S ADS	D	C	A	5.5x	22.3%	93.0%	6.8%	$37.00
VTRSViatris Inc. Common Stock	B	C	A	1.5x	4.4%	40.3%	—	$18.66
INSMInsmed, Inc.	F	A	C	18.5x	185.8%	83.5%	—	$96.27
ASNDAscendis Pharma A/S Ordinary Share	D	A	B	11.9x	113.3%	91.3%	—	$225.25
JAZZJazz Pharmaceuticals, Inc.	B	C	B	3.0x	12.6%	88.4%	-1.4%	$210.23
BBIOBridgeBio Pharma, Inc. Common Stock	F	A	B	18.2x	202.4%	94.4%	—	$66.39
CORTCorcept Therapeutics Inc.	F	C	A	14.3x	16.0%	98.3%	-0.5%	$110.16
ELANElanco Animal Health Incorporated Common Stock	D	B	B	2.3x	11.9%	55.4%	29.9%	$23.55
SMMTSummit Therapeutics Inc. Common Stock	F	—	C	12187.5x	—	—	—	$14.63
RDYDr. Reddy's Laboratories Limited American Depositary Shares	D	C	B	3.1x	-0.9%	61.4%	16.5%	$13.07
BMRNBioMarin Pharmaceuticals Inc	C	C	B	3.1x	11.2%	79.6%	-17.0%	$54.68
MDGLMadrigal Pharmaceuticals, Inc. Common Stock	D	A	C	8.1x	149.0%	91.5%	—	$449.74
CRNXCrinetics Pharmaceuticals, Inc.	F	A	A	213.8x	2928.4%	—	—	$84.95
CYTKCytokinetics Inc.	F	D	B	127.3x	-21.1%	—	—	$61.95
PTGXProtagonist Therapeutics, Inc	F	B	B	29.5x	34.8%	—	—	$128.75
TGTXTG Therapeutics, Inc.	D	B	B	10.3x	76.1%	82.4%	—	$53.97
AXSMAxsome Therapeutics, Inc	D	B	C	10.6x	56.9%	93.2%	—	$157.14
ARWRArrowhead Research Corporation	D	A	C	11.8x	16.9%	—	—	$55.90
ABVXAbivax SA American Depositary Shares	—	—	C	—	—	—	—	$88.13
SYRESpyre Therapeutics, Inc. Common Stock	—	—	B	5995.2x	—	—	—	$79.90
IONSIonis Pharmaceuticals, Inc. Common Stock	D	D	C	8.2x	-7.5%	98.2%	—	$42.94
ALKSAlkermes Inc. plc	D	C	B	4.1x	10.8%	84.6%	—	$41.22
PRAXPraxis Precision Medicines, Inc. Common Stock	F	—	B	789.2x	—	—	—	$241.76
AMRXAmneal Pharmaceuticals, Inc. Class A Common Stock	D	C	A	2.0x	9.3%	39.3%	-18.4%	$19.18
KNSAKiniksa Pharmaceuticals International, plc Class A Ordinary Shares	D	B	A	7.3x	58.9%	89.8%	—	$78.59
RYTMRhythm Pharmaceuticals, Inc. Common Stock	F	B	C	24.7x	53.5%	70.9%	—	$86.17
LGNDLigand Pharmaceuticals Inc.	D	B	B	20.3x	54.9%	95.4%	—	$295.54
BLTEBelite Bio, Inc American Depositary Shares	—	—	B	—	—	—	—	$142.78

About Optimi Health Corp. Common Shares

Optimi Health Corp operates in developing a vertically integrated Canadian functional mushroom brand that focuses on the health and wellness sector. The company has one reportable operating segment being that of the farming, processing, and distribution of raw mushroom biomass. It also intends to cultivate, extract, process, and distribute strains of fungi products at its facilities located in Princeton, British Columbia.